Granules Pharmaceuticals Inc. Receives FDA Tentative Approval for Generic Amphetamine Extended-Release Orally Disintegrating Tablets Read more
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Travoprost Ophthalmic Solution USP, 0.004% (Ionic Buffered Solution) Read more
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Loteprednol Etabonate and Tobramycin Ophthalmic Suspension. Read more
CPHI & PMEC India Uniting over 50,000 Professionals and Global Leaders to Shape the Future of Pharma Industry Read more